Dr. Paul Dorian, MD, CM, MSc., Cardiologist, discusses atrial fibrillation treatment options.

The continued success of abelacimab throughout the AZALEA-TIMI 71 trials helps draw the drug closer to FDA approval, stated ...

Researchers from Queen Mary University of London have developed an AI tool that creates synthetic yet medically accurate ...

The study is geared toward patients with atrial fibrillation, or AFib ... while others will use the "pill-in-pocket" treatment in which the pills are taken as needed using a study app on an ...